Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Biomedicines|July 27, 2022
Proteomic Assessment of C57BL/6 Hippocampi after Non-Selective Pharmacological Inhibition of Nitric Oxide Synthase Activity: Implications of Seizure-like Neuronal Hyperexcitability Followed by TauopathyJhana O Hendrickx, Charlotte Adams, Anne Sieben, et al.
Clinical & Experimental Optometry|December 23, 2015
Fast circulation of cerebrospinal fluid: an alternative perspective on the protective role of high intracranial pressure in ocular hypertensionPeter Wostyn, Veva De Groot, Debby Van Dam, et al.
The European Journal of Neuroscience|January 25, 2003
Age-dependent cognitive decline in the APP23 model precedes amyloid depositionDebby Van Dam, Rudi D'Hooge, Matthias Staufenbiel, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 20, 2018
Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosisJana Janssens, Yannick Vermeiren, Erik Fransen, et al.
Neurochemistry International|December 29, 2009
Excitatory amino acids and monoaminergic neurotransmitters in cerebrospinal fluid of acute ischemic stroke patientsRaf Brouns, An Van Hemelrijck, Wilhelmus H Drinkenburg, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2016
Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's DiseaseYannick Vermeiren, Jana Janssens, Tony Aerts, et al.
Neurochemistry International|September 23, 2021
5-HT<sub>7</sub> receptors in Alzheimer's diseaseMaite Solas, Debby Van Dam, Jana Janssens, et al.
Expert Opinion on Pharmacotherapy|January 29, 2013
Aripiprazole in the treatment of Alzheimer's diseasePeter Paul De Deyn, Annemieke F J Drenth, Berry P Kremer, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2011
Region- and age-specific changes in glutamate transport in the AβPP23 mouse model for Alzheimer's diseaseAnneleen Schallier, Ilse Smolders, Debby Van Dam, et al.
Behavioural Brain Research|May 7, 2005
Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS)Debby Van Dam, Vanessa Errijgers, R Frank Kooy, et al.
Pageof 12